117 related articles for article (PubMed ID: 11481138)
1. Antipsychotic treatment of behavioral and psychological symptoms of dementia in geropsychiatric inpatients.
Edell WS; Tunis SL
Am J Geriatr Psychiatry; 2001; 9(3):289-97. PubMed ID: 11481138
[TBL] [Abstract][Full Text] [Related]
2. Assessing antipsychotic effectiveness in dementia with the factor structure of the Psychogeriatric Dependency Rating Scale (PGDRS).
Adams BE; Tunis SL; Edell WS
J Am Med Dir Assoc; 2003; 4(2):61-6. PubMed ID: 12807576
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the efficacy of new and conventional antipsychotic drugs in the treatment of behavioral and psychological symptoms of dementia (BPSD).
Gareri P; Cotroneo A; Lacava R; Seminara G; Marigliano N; Loiacono A; De Sarro G
Arch Gerontol Geriatr Suppl; 2004; (9):207-15. PubMed ID: 15207416
[TBL] [Abstract][Full Text] [Related]
4. Introduction: antipsychotic treatment of behavioral and psychological symptoms of dementia in geropsychiatric patients.
Madhusoodanan S
Am J Geriatr Psychiatry; 2001; 9(3):283-8. PubMed ID: 11481137
[No Abstract] [Full Text] [Related]
5. The effects of olanzapine in reducing the emergence of psychosis among nursing home patients with Alzheimer's disease.
Clark WS; Street JS; Feldman PD; Breier A
J Clin Psychiatry; 2001 Jan; 62(1):34-40. PubMed ID: 11235926
[TBL] [Abstract][Full Text] [Related]
6. Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group.
Street JS; Clark WS; Gannon KS; Cummings JL; Bymaster FP; Tamura RN; Mitan SJ; Kadam DL; Sanger TM; Feldman PD; Tollefson GD; Breier A
Arch Gen Psychiatry; 2000 Oct; 57(10):968-76. PubMed ID: 11015815
[TBL] [Abstract][Full Text] [Related]
7. Behavioral and psychological symptoms of dementia (BPSD) in elderly demented subjects: is the long lasting use of atypical antipsychotic drugs useful and safe?
Angelini A; Bendini C; Neviani F; Neri M
Arch Gerontol Geriatr; 2007; 44 Suppl 1():35-43. PubMed ID: 17317431
[TBL] [Abstract][Full Text] [Related]
8. The effects of antipsychotic drug treatment on prolactin concentrations in elderly patients.
Kinon BJ; Stauffer VL; McGuire HC; Kaiser CJ; Dickson RA; Kennedy JS
J Am Med Dir Assoc; 2003; 4(4):189-94. PubMed ID: 12837139
[TBL] [Abstract][Full Text] [Related]
9. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.
Volavka J; Czobor P; Sheitman B; Lindenmayer JP; Citrome L; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
Am J Psychiatry; 2002 Feb; 159(2):255-62. PubMed ID: 11823268
[TBL] [Abstract][Full Text] [Related]
10. Comparison of olanzapine and risperidone in the treatment of psychosis and associated behavioral disturbances in patients with dementia.
Deberdt WG; Dysken MW; Rappaport SA; Feldman PD; Young CA; Hay DP; Lehman DL; Dossenbach M; Degenhardt EK; Breier A
Am J Geriatr Psychiatry; 2005 Aug; 13(8):722-30. PubMed ID: 16085789
[TBL] [Abstract][Full Text] [Related]
11. The management of psychogeriatric patient.
Zannino G; Gargiulo A; Lamenza F; Marotta MG; Barzotti T; Silvestri A; Ettorre E; Marigliano V
Arch Gerontol Geriatr Suppl; 2004; (9):465-70. PubMed ID: 15207448
[TBL] [Abstract][Full Text] [Related]
12. Olanzapine for psychotic and behavioral disturbances in Alzheimer disease.
Schatz RA
Ann Pharmacother; 2003 Sep; 37(9):1321-4. PubMed ID: 12921516
[TBL] [Abstract][Full Text] [Related]
13. Safety profile assessment of risperidone and olanzapine in long-term care patients with dementia.
Martin H; Slyk MP; Deymann S; Cornacchione MJ
J Am Med Dir Assoc; 2003; 4(4):183-8. PubMed ID: 12837138
[TBL] [Abstract][Full Text] [Related]
14. The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia.
David SR; Taylor CC; Kinon BJ; Breier A
Clin Ther; 2000 Sep; 22(9):1085-96. PubMed ID: 11048906
[TBL] [Abstract][Full Text] [Related]
15. A pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: a double-blind, randomized, 8-week trial.
Sikich L; Hamer RM; Bashford RA; Sheitman BB; Lieberman JA
Neuropsychopharmacology; 2004 Jan; 29(1):133-45. PubMed ID: 14583740
[TBL] [Abstract][Full Text] [Related]
16. Behavioral and psychological symptoms in patients with dementia as a target for pharmacotherapy with risperidone.
Rabinowitz J; Katz IR; De Deyn PP; Brodaty H; Greenspan A; Davidson M
J Clin Psychiatry; 2004 Oct; 65(10):1329-34. PubMed ID: 15491235
[TBL] [Abstract][Full Text] [Related]
17. Olanzapine as a treatment of neuropsychiatric disorders of Alzheimer's disease and other dementias: a 24-month follow-up of 68 patients.
Moretti R; Torre P; Antonello RM; Cazzato G; Griggio S; Bava A
Am J Alzheimers Dis Other Demen; 2003; 18(4):205-14. PubMed ID: 12955785
[TBL] [Abstract][Full Text] [Related]
18. Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder.
Bilder RM; Goldman RS; Volavka J; Czobor P; Hoptman M; Sheitman B; Lindenmayer JP; Citrome L; McEvoy J; Kunz M; Chakos M; Cooper TB; Horowitz TL; Lieberman JA
Am J Psychiatry; 2002 Jun; 159(6):1018-28. PubMed ID: 12042192
[TBL] [Abstract][Full Text] [Related]
19. Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia.
Citrome L; Volavka J; Czobor P; Sheitman B; Lindenmayer JP; McEvoy J; Cooper TB; Chakos M; Lieberman JA
Psychiatr Serv; 2001 Nov; 52(11):1510-4. PubMed ID: 11684748
[TBL] [Abstract][Full Text] [Related]
20. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.
Lindenmayer JP; Czobor P; Volavka J; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
Am J Psychiatry; 2003 Feb; 160(2):290-6. PubMed ID: 12562575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
